Role of deep brain stimulation in modulating memory formation and recall.

Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Neurosurgical FOCUS (Impact Factor: 2.14). 08/2009; 27(1):E3. DOI: 10.3171/2009.4.FOCUS0975
Source: PubMed

ABSTRACT Deep brain stimulation (DBS) has become an increasingly popular tool for treating a variety of medically refractory neurological and psychiatric disorders such as Parkinson disease, essential tremor, depression, and obsessive-compulsive disorder. Several targets have been identified for ablation or stimulation based on their anatomical location and presumed function. Areas such as the subthalamic nucleus, globus pallidus, and thalamus, for example, are believed to play a key role in motor control and execution, and they are commonly used in the treatment of motor disorders. Limbic structures such as the cingulate cortex and ventral striatum, believed to be important in motivation, emotion, and higher cognition, have also been targeted for treatment of a number of psychiatric disorders. In all of these settings, DBS is largely aimed at addressing the deleterious aspects of these diseases. In Parkinson disease, for example, DBS has been used to reduce rigidity and tremor, whereas in obsessive-compulsive disorder it has been used to limit compulsive behavior. More recently, however, attention has also turned to the potential use of DBS for enhancing or improving otherwise nonpathological aspects of cognitive function. This review explores the potential role of DBS in augmenting memory formation and recall, and the authors discuss recent studies and future trends in this emerging field.

Download full-text


Available from: Ziv Williams, Mar 17, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Based on evidence suggesting that deep brain stimulation (DBS) may promote certain cognitive processes, we have been interested in developing DBS as a means of mitigating memory and learning impairments in Alzheimer’s disease (AD). In this study we used an animal model of AD (TgCRND8 mice) to determine the effects of high-frequency stimulation (HFS) on non-amyloidogenic α-secretase activity and DBS in short-term memory. We tested our hypothesis using hippocampal slices (in vitro studies) from TgCRND8 mice to evaluate whether HFS increases α-secretase activity (non-amyloidogenic pathway) in the CA1 region. In a second set of experiments, we performed in vivo studies to evaluate whether DBS in midline thalamic region re-establishes hippocampal dependent short-term memory in TgCRND8 mice. The results showed that application of HFS to isolated hippocampal slices significantly increased synaptic plasticity in the CA1 region and promoted a 2-fold increase of non-amyloidogenic α-secretase activity, in comparison to low frequency stimulated controls from TgCRND8 mice. In the in vivo studies, DBS treatment facilitated acquisition memory in TgCRND8 mice, in comparison to their own baseline before treatment. These results provide evidence that DBS could enhance short-term memory in a mouse model of AD by increasing synaptic transmission and α-secretase activity in the CA1 region of hippocampus. KeywordsAlzheimer’s disease-Deep brain stimulation-Hippocampus-LTP-Neuronal transmission Synaptic plasticity-Memory-TgCRND8 mice-Thalamus
    06/2010; 1(2):170-176. DOI:10.2478/v10134-010-0026-7
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: From the advent of electroconvulsive therapy in the 1930s to the emergence of magnetic seizure therapy in the 2000s, the refinement of brain stimulation in psychiatry has been largely motivated by a desire to achieve clinical efficacy and eliminate cognitive adverse effects. As a result of these efforts, a clinically efficacious brain stimulation technique that does not negatively affect cognition could soon be available. In the course of developing a 'cognitively safe' brain stimulation technique, potential methods to enhance various aspects of cognition have also emerged. In this article, we discuss the past, present and future of brain stimulation in psychiatry, and its effects on cognition.
    Nature Reviews Neurology 04/2010; 6(5):267-75. DOI:10.1038/nrneurol.2010.30 · 14.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The use of neuromodulation as a treatment for major depressive disorder (MDD) has recently attracted renewed interest due to development of other non-pharmacological therapies besides electroconvulsive therapy (ECT) such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), deep brain stimulation (DBS), and vagus nerve stimulation (VNS). We convened a working group of researchers to discuss the updates and key challenges of neuromodulation use for the treatment of MDD. The state-of-art of neuromodulation techniques was reviewed and discussed in four sections: [1] epidemiology and pathophysiology of MDD; [2] a comprehensive overview of the neuromodulation techniques; [3] using neuromodulation techniques in MDD associated with non-psychiatric conditions; [4] the main challenges of neuromodulation research and alternatives to overcome them. ECT is the first-line treatment for severe depression. TMS and tDCS are strategies with a relative benign profile of side effects; however, while TMS effects are comparable to antidepressant drugs for treating MDD; further research is needed to establish the role of tDCS. DBS and VNS are invasive strategies with a possible role in treatment-resistant depression. In summary, MDD is a chronic and incapacitating condition with a high prevalence; therefore clinicians should consider all the treatment options including invasive and non-invasive neuromodulation approaches.
    Arquivos de neuro-psiquiatria 06/2010; 68(3):433-51. DOI:10.1590/S0004-282X2010000300021 · 1.01 Impact Factor